Comparative efficacy of treatments for previously treated patients with advanced esophageal and esophagogastric junction cancer: A network meta-analysis.
<h4>Background</h4>It remains unclear which treatment is the most effective for previously treated patients with advanced esophageal and esophagogastric junction (EGJ) cancer. We conducted a network meta-analysis to address this important issue.<h4>Methods</h4>PubMed, Embase,...
Guardado en:
Autores principales: | Shuiyu Lin, Tingting Liu, Jun Chen, Guang Li, Jun Dang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9b40e6044c274efba4feb25233a434d5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Long-Term Efficacy of Neoadjuvant Concurrent Chemoradiotherapy for Potentially Resectable Advanced Siewert Type II and III Adenocarcinomas of the Esophagogastric Junction
por: Yuan Tian, et al.
Publicado: (2021) -
Modified Systemic Inflammation Score Is an Independent Predictor of Long-Term Outcome in Patients Undergoing Surgery for Adenocarcinoma of the Esophagogastric Junction
por: Jianping Xiong, et al.
Publicado: (2021) -
Prediction of esophagogastric varices associated with oxaliplatin administration
por: Yosuke Satta, et al.
Publicado: (2021) -
Survival Benefit of Pyloric Lymph Node Dissection for Siewert Type II/III Adenocarcinoma of the Esophagogastric Junction Based on Tumor Diameter: A Large Cohort Study
por: Xia Lin, et al.
Publicado: (2021) -
Capecitabine, 5-fluorouracil and S-1 based regimens for previously untreated advanced oesophagogastric cancer: A network meta-analysis
por: Emil ter Veer, et al.
Publicado: (2017)